- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Revlimid
Total 586 results
-
Dana-Farber Cancer InstituteNovartisCompletedMultiple Myeloma in RelapseUnited States
-
Merck Sharp & Dohme LLCTerminated
-
University Hospital, ToulouseTakeda; CelgeneTerminated
-
National Cancer Institute (NCI)CompletedRecurrent Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Recurrent Adult Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Recurrent Lymphoplasmacytic Lymphoma | AIDS-Related Hodgkin LymphomaUnited States
-
CelgeneCompletedLymphoma, Mantle-Cell | Mantle Cell LymphomaFrance, United Kingdom, Belgium, Spain, Denmark, Germany, Israel, Russian Federation, Italy, Poland, Netherlands, Sweden, Greece, Czechia
-
Weill Medical College of Cornell UniversityPfizer; Celgene CorporationTerminatedMultiple MyelomaUnited States
-
Geron CorporationCompletedMultiple MyelomaUnited States
-
King's College Hospital NHS TrustCompleted
-
Boehringer IngelheimTerminated
-
National Cancer Institute (NCI)RecruitingLymphoma | Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Non-Hodgkin LymphomaUnited States
-
Sun Yat-sen UniversityRecruitingMyeloma | Newly Diagnosed | High RiskChina
-
National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Ann Arbor Stage I Small Lymphocytic Lymphoma | Ann Arbor Stage II Small Lymphocytic Lymphoma | Chronic Lymphocytic Leukemia... and other conditionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; AmgenWithdrawn
-
Fondazione EMN Italy OnlusCompleted
-
University of PennsylvaniaCompletedMyelomaUnited States
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene CorporationActive, not recruitingMyeloma, MultipleUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Multiple Myeloma Research Consortium; Blood Cancer Research...CompletedSmoldering Multiple MyelomaUnited States
-
Wuerzburg University HospitalClinAssess GmbH; Arbeitsgemeinschaft medikamentoese TumortherapieActive, not recruitingNewly Diagnosed Multiple MyelomaGermany, Austria
-
Gesellschaft fur Medizinische Innovation - Hamatologie...ClinAssess GmbHCompletedMultiple MyelomaGermany
-
Vaishali SanchorawalaCelgene CorporationCompletedMultiple MyelomaUnited States
-
PETHEMA FoundationCelgene; Janssen-Cilag Ltd.; TFS Trial Form SupportCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationTerminated
-
Tiziana MarangonWithdrawn
-
M.D. Anderson Cancer CenterJanssen Services, LLCCompleted
-
OncotherapeuticsKaryopharm Therapeutics IncRecruitingRefractory Multiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingSezary Syndrome | Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma | Folliculotropic Mycosis Fungoides | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Cutaneous...United States
-
Mario BoccadoroActive, not recruiting
-
Merck Sharp & Dohme LLCCompletedRelapsed or Refractory Multiple Myeloma
-
Mayo ClinicCompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IVA Laryngeal Squamous Cell... and other conditionsUnited States
-
PfizerRecruitingMultiple MyelomaUnited States, Canada
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); National Marrow Donor Program; Blood and Marrow...CompletedMultiple MyelomaUnited States
-
AmgenTerminated
-
CelgeneCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbWithdrawnMultiple Myeloma | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell... and other conditionsUnited States
-
Hoffmann-La RocheCompleted
-
University Health Network, TorontoCompletedMultiple Myeloma | Renal FailureCanada
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
Xia ZhongjunAntengene CorporationRecruiting
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaUnited States, Spain, France, Greece
-
University of ChicagoNational Cancer Institute (NCI)Active, not recruitingStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, Canada
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbTerminatedMultiple MyelomaUnited States
-
Yazeed SawalhaWithdrawnRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular... and other conditions
-
Novartis PharmaceuticalsTerminated
-
CelgeneCompletedMultiple MyelomaSpain, United Kingdom, Switzerland, Australia, Israel, Italy, Poland, France, Belgium, Ireland, Austria, Germany, Ukraine, Greece, Sweden
-
Boston Medical CenterCompletedMultiple MyelomaUnited States
-
Juan DuRecruitingMultiple MyelomaChina
-
National Cancer Institute (NCI)Active, not recruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Myelodysplastic Syndrome With Excess Blasts-1 | Myelodysplastic Syndrome/Acute Myeloid LeukemiaCanada, United States